DeSimone’s current interests are focused on applied fabrication technologies from the microelectronics industry to make nanocarriers for use in medicine. Dr. DeSimone holds more than 115 issued patents with more than 70 new patent applications pending, and he has published more than 240 peer-reviewed scientific articles. In 2005, Dr. DeSimone was elected into both the National Academy of Engineering and the American Academy of Arts and Sciences. DeSimone has received numerous awards and recognition, including the Lemelson-MIT Prize, Presidential Green Chemistry Challenge Award (1997), the Engineering Excellence Award by DuPont (2002), and the American Chemical Society Award for Creative Invention (2005). He is the cofounder of Liquidia Technologies, Inc., and a cofounder of BioStent which was sold to Guidant (now Abbott Vascular). He has served on the DELS Board on Chemical Sciences and Technology. Dr. DeSimone earned his B.S. in chemistry from Ursinus College and his Ph.D. in chemistry from the Virginia Polytechnic Institute and State University.

Michael S. Ascher is the Senior Medical Advisor to the California Emergency Management Agency (CALEMA) and a visiting researcher in the Department of Medicine and Epidemiology, University of California (Davis) School of Veterinary Medicine. Previously, he has been the lead for biological defense activities in the California Department of Health Services and principal investigator of the CDC grant to the state for preparedness and response. Other past positions include chief of the Viral and Rickettsial Laboratory, Division of Communicable Disease Control, at the California Department of Health Services. He also served in the U.S. Army as chief of medicine and in the Bacteriology Division at U.S. Army Medical Research Institute of Infectious Disease. In the area of biological defense, he has served on the Armed Forces Epidemiological Board and an interagency advisory panel on Biological Warfare Preparedness for the 21st Century and has consulted for the Department of Defense, Centers for Disease Control and Prevention, MITRE Corporation, the National Domestic Preparedness Office of the FBI, and others. Dr. Ascher’s research interests include mechanisms of protective immunogenicity of microbial vaccines and advanced methods for diagnosis of infectious diseases. He currently serves on the National Academies Standing Committee on Biodefense at the U.S. Department of Defense. Dr. Ascher received his M.D. from Harvard Medical School.

James W. Buehler is a Research Professor in the Department of Epidemiology and a member of the Center for Public Health Preparedness and Research at the Rollins School of Public Health at Emory University. Prior to joining the Emory faculty in 2002, he served for 21 years in the U.S. Public Health Service as a medical epidemiologist at the Centers for Disease Control and Prevention (CDC), where he worked in the areas of general field epidemiology, maternal and child health, HIV/AIDS, and, for a brief period in 2001, anthrax. His work in public health surveillance—population health monitoring—has spanned analysis, development, management, application of surveillance information to programs and policies, and ethics. Dr. Buehler’s applied research interests center on improving public health capacity to detect and respond to epidemics and other community health emergencies and on improving the use of epidemiology in public health systems and practice.

Karen S. Cook is the Ray Lyman Wilbur Professor of Sociology at Stanford University, chair of the Department of Sociology, and director of the Institute for Research in the Social Sciences (IRISS). She joined the faculty of the Department of Sociology in academic year 1998–1999. Before coming to Stanford she was on the faculties of the University of Washington and of Duke

The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement